Research & News
New studies, trial results, publications and industry news. 40 discussions in this community. Create a free account to ask a question or share your experience.
Discussions in Research & News
- Larazotide moving beyond celiac into broader gut permeability research, anyone tracking this? - 3 points, 0 comments
- Thoughts on the Nootropic God Stack after reading the latest overview - 3 points, 4 comments
- Methylene blue for mitochondrial support, anyone actually tried low dose cycling? - 3 points, 5 comments
- GlyNAC trial in older adults, glutathione restoration looks legit but questions remain - 4 points, 7 comments
- MK-677 and insulin resistance, long-term data still missing - 4 points, 6 comments
- Novo Nordisk wins Dutch injunction against compounded semaglutide nasal spray - 4 points, 5 comments
- FDA reviewing seven peptides for compounding list, what could this mean for access? - 5 points, 5 comments
- AI and Quantum Computing Are Now Designing New Peptides - 10 points, 4 comments
- FDA advisory panel narrowly backs several research peptides, kinda wild - 5 points, 5 comments
- Recent PE 22-28 preprint sparks curiosity – what do you think? - 14 points, 4 comments
- Optima peptide co (Best supplier) - 4 points, 4 comments
- RCSI team in Dublin develops mRNA vaccine for childhood neuroblastoma - 4 points, 4 comments
- FDA panel may greenlight peptide production, is the bonanza real or just hype? - 4 points, 2 comments
- Brazilian researchers try a peptide approach for parkinson's, early but interesting - 3 points, 4 comments
- Tirzepatide and muscle preservation, what the GIP angle actually changes - 1 points, 4 comments
- FDA Peptide Reversal, What Actually Changes For Us? - 2 points, 4 comments
- GLP-1 patent cliffs and the generic wave coming for semaglutide - 3 points, 4 comments
- Former LifeMD workers say profits came before patient safety on GLP-1s - 2 points, 4 comments
- Doc warns against DIY longevity, has a point but misses the mark - 1 points, 4 comments
- Stanford finally says out loud what half this forum has been screaming for a year - 2 points, 4 comments
- UK bust on unlicensed retatrutide and tirzepatide pens, sad but expected - 1 points, 6 comments
- Hong kong doubling down on biotech incubation, what could trickle out - 2 points, 4 comments
- GLP-1 patients reporting muscle loss, what does the imaging research say now - 2 points, 6 comments
- Life Biosciences just dosed a human with a cellular reprogramming shot - 0 points, 4 comments
- Brazilian sisters over 100 studied for longevity clues - 1 points, 6 comments
- Trump fda cracks down on telehealth drug ads, glp-1s in the crosshairs - 3 points, 4 comments
- Nature asks if living to 150 is realistic, and I'm not sold - 3 points, 4 comments
- VIP peptide caught my eye, anyone looked at the CIRS/mold research? - 4 points, 6 comments
- ACE-031 trial data from years back still worth a look, what do you think? - 1 points, 4 comments
- Everlab saying no to peptides, reckon more clinics will follow - 2 points, 4 comments
- The peptide problem: hype is outrunning the evidence, and it needed to be said - 2 points, 4 comments
- Stanford piece on compounded GLP-1s, doctors are worried and the FDA is finally catching up - 2 points, 4 comments
- BBC says we might reverse grey hair. I will believe it when I see my own roots come back brown. - 3 points, 3 comments
- Telehealth GLP-1 boom is outpacing the safety net, and it shows - 3 points, 4 comments
- China's NMPA is tightening the screws on contract peptide manufacturers, and we should probably pay attention - 1 points, 4 comments
- NYT piece on Chinese peptides flooding Silicon Valley, does the supply chain actually worry anyone - 1 points, 4 comments
- Parabilis and its corkscrew-shaped peptides, $305M says the bet is real - 3 points, 6 comments
- FDA peptides panel packed with industry tied docs, does that change anything for us - 3 points, 4 comments
- PRImus-AD: an oral peptide that targets the actual bad guy in Alzheimer - 3 points, 4 comments
- DOI as a 5-HT2A research tool, why does it get ignored in longevity talk? - 2 points, 4 comments
Related compounds
- BPC-157 - Body Protection Compound-157
- TB-500 - Thymosin Beta-4 (Synthetic)
- Pentosan Polysulfate - Pentosan Polysulfate Sodium
- KPV - Lysine-Proline-Valine Tripeptide
- Thymosin Beta-4 - Thymosin Beta-4 (Full Length)
- LL-37 - Cathelicidin Antimicrobial Peptide LL-37
- AOD-9604 - Advanced Obesity Drug Fragment 176-191 (Modified)
- Semaglutide - Semaglutide (GLP-1 Receptor Agonist)
Community discussion - research and educational context only. Not medical advice.